Joint Corp (NASDAQ:JYNT) Director Ronald V. Davella sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $7.62, for a total transaction of $22,860.00. Following the completion of the transaction, the director now owns 15,797 shares of the company’s stock, valued at $120,373.14. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Joint stock traded down $0.19 during midday trading on Thursday, hitting $7.50. 404 shares of the company traded hands, compared to its average volume of 28,383. The firm has a market capitalization of $105.61 million, a PE ratio of -29.96 and a beta of 1.02. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.75. Joint Corp has a 12 month low of $4.67 and a 12 month high of $9.64.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, November 8th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The company had revenue of $8.06 million for the quarter, compared to the consensus estimate of $7.98 million. Joint had a negative net margin of 2.68% and a negative return on equity of 21.00%. As a group, research analysts anticipate that Joint Corp will post 0.06 earnings per share for the current year.

Several equities analysts have recently commented on JYNT shares. Zacks Investment Research upgraded shares of Joint from a “hold” rating to a “buy” rating and set a $9.75 target price for the company in a research report on Wednesday, August 15th. Roth Capital restated a “buy” rating on shares of Joint in a research report on Friday, August 10th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Joint currently has an average rating of “Buy” and an average target price of $10.58.

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Joint by 7.0% during the 3rd quarter. Vanguard Group Inc. now owns 276,974 shares of the company’s stock valued at $2,368,000 after purchasing an additional 18,099 shares during the last quarter. Granite Investment Partners LLC grew its holdings in shares of Joint by 40.5% during the 3rd quarter. Granite Investment Partners LLC now owns 79,492 shares of the company’s stock valued at $680,000 after purchasing an additional 22,900 shares during the last quarter. Advisory Services Network LLC grew its holdings in shares of Joint by 42.6% during the 3rd quarter. Advisory Services Network LLC now owns 27,780 shares of the company’s stock valued at $238,000 after purchasing an additional 8,299 shares during the last quarter. Acadian Asset Management LLC grew its holdings in shares of Joint by 25.1% during the 3rd quarter. Acadian Asset Management LLC now owns 177,843 shares of the company’s stock valued at $1,522,000 after purchasing an additional 35,716 shares during the last quarter. Finally, Perkins Capital Management Inc. grew its holdings in shares of Joint by 33.0% during the 3rd quarter. Perkins Capital Management Inc. now owns 68,500 shares of the company’s stock valued at $586,000 after purchasing an additional 17,000 shares during the last quarter. 51.43% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This article was first published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://theolympiareport.com/2018/12/06/insider-selling-joint-corp-jynt-director-sells-3000-shares-of-stock.html.

Joint Company Profile

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of August 9, 2018, the company operated approximately 400 clinics. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.

Further Reading: What are Institutional Investors?

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.